The influence of prescription monitoring programs on chronic pain management

The burden of the nonmedical use of prescription opioid analgesics. Joining Europe PMC. Tools Tools overview. ORCID article claiming. Journal list. Grant finder. External links service. Annotations submission service. Developers Developer resources. API case studies. SOAP web service. Annotations API. OAI service. Bulk downloads. Developers Forum. Search syntax reference. Contact us Helpdesk. Tech blog. Developer forum. Let us know how we are doing. These databases aid law enforcement agencies in investigations of narcotic trafficking; they also help state regulatory boards to monitor improper prescription practices.

Objective: This manuscript examines the basic structure of a PMP, including the way the data are collected and the way these data are stored and used.

It also looks at the organizational differences amongst state programs. NASPER and Harold Rogers are two federal programs that provide funding to the state PMPs, and the current study examines the differences as well as similarities between these 2 programs. This study also compares the results of 2 reports: the U. General Accounting Office Study and the Twillman study.

For the Medicare Advantage recipients, For all individuals, living in regions with robust and strongly robust PDMPs increased the rate of opioid discontinuation without tapering. This study may have been limited by defining opioid discontinuation by a relatively short gap in use 30 days , according to the investigators. These data indicate that strongly robust PDMPs may be preventing long-term opioid use from escalating to use of high opioid doses among the Medicare Advantage population, the authors wrote.

Abrupt discontinuation of long-term opioid use without a tapering period may be of concern and should be investigated, they concluded. Robust prescription monitoring programs and abrupt discontinuation of long-term opioid use.

Am J Prev Med. See the table in the Adherence Monitoring section to see examples of addictive and nonaddictive behaviors. The Adherence Monitoring page also explains screening tools and drug tests that are used to maintain adherence to a treatment regimen.

A doctor who has suspicions should rely on close observation, testing, and involvement of other clinicians, such as psychiatrists or drug treatment specialists. And, relying on a written doctor-patient agreement that details the treatment process and the patient's obligations can put the patient in a less defensive mood.

The Informed Consent section has a sample doctor-patient agreement. The goal of treatment is not just to make the chronic pain patient feel better, but also to restore vestiges of normal life. Skip to site content. Department of Health and Human Services. Read the latest info. Toggle navigation. Pain Management Monitoring. Open All Close All. Verifying Functional Goals.

Prescription Drug Monitoring Programs. These programs have a variety of purposes and goals, which include: Supporting medication safety and legitimate medical access to controlled substances Determining individuals who may be misusing, abusing or diverting drugs and preventing them access to controlled substances Assisting in the identification of individuals addicted to controlled prescription medications and intervening with treatment when necessary Influencing public health legislative and financial agendas by presenting prescription medication use data Educating the public about the purpose of PDMPs and the issues surrounding prescription drugs.

Adherence Monitoring.